Tumor microenvironment
11 – 20 of 1970
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Role of Amide Proton Transfer Weighted MRI in Predicting MGMTp Methylation Status, p53-Status, Ki-67 Index, IDH-Status, and ATRX Expression in WHO Grade 4 High Grade Glioma
- Contribution to journal › Article
-
Mark
Cellular and biophysical barriers to lipid nanoparticle mediated delivery of RNA to the cytosol
- Contribution to journal › Article
-
Mark
Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppression
- Contribution to journal › Article
-
Mark
Seizure-Related Homolog Protein 6 (SEZ6) : Biology and Therapeutic Target in Neuroendocrine Carcinomas
- Contribution to journal › Scientific review
-
Mark
Availability and use of PET in patients with brain tumours – a European Organisation for Research and Treatment of Cancer - Brain Tumour Group (EORTC-BTG) survey
- Contribution to journal › Article
-
Mark
Antisecretory factor as add-on treatment for newly diagnosed glioblastoma, IDH wildtype : study protocol for a randomized double-blind placebo-controlled trial
- Contribution to journal › Article
-
Mark
Not All Tumors Are Alike : Varying Efficacy of FLASH Across Tumor Types and Oxygenation Status in Spheroid Models
(2025) In The British journal of radiology
- Contribution to journal › Article
-
Mark
Injectable bioresorbable conductive hydrogels for multimodal brain tumor electroimmunotherapy
- Contribution to journal › Article
-
Mark
Optimizing peptide nucleic acid-based pretargeting for enhanced targeted radionuclide therapy
- Contribution to journal › Article
- 2024
-
Mark
Population pharmacokinetic–pharmacodynamic model of subcutaneous bupivacaine in a novel extended-release microparticle formulation
- Contribution to journal › Article
